To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Short- and long-course levofloxacin plus rifampicin for prosthetic joint infection

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
January 2017

Short- and long-course levofloxacin plus rifampicin for prosthetic joint infection

Vol: 6| Issue: 1| Number:20| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: a randomised clinical trial

Int J Antimicrob Agents. 2016 Sep;48(3):310-6

Contributing Authors:
J Lora-Tamayo G Euba J Cobo JP Horcajada A Soriano E Sandoval C Pigrau N Benito L Falgueras J Palomino Del Toro A Jover-Sáenz JA Iribarren M Sánchez-Somolinos A Ramos M Fernández-Sampedro M Riera JM Baraia-Etxaburu J Ariza Prosthetic

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

63 patients with a hip or knee prosthetic joint infection by either Staphylococcus aureus or coagulase-negative staphylococci were randomized to either 8 weeks of levofloxacin and rifampicin following debridement, or 3- and 6-months levofloxacin and rifampicin following debridement (3 months for hip infection and 6 months for knee infection). The purpose of this study was to compare infection cure...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue